 REDWOOD CITY, Calif., Sept. 28, 2021 GLOBE NEWSWIRE -- PROCEPT BioRobotics Corporation Nasdaq: PRCT, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced a new positive coverage decision from Cigna, expanding access to Aquablation therapy for the treatment of their members with Benign Prostatic Hyperplasia. The revised policy is effective September 15, 2021. 